Last reviewed · How we verify
Huangqi-Guizhi-Wuwu granules
Huangqi-Guizhi-Wuwu granules is a Small molecule drug developed by Nanjing NingQi Medicine Science and Technology Co., Ltd.. It is currently in Phase 3 development for Cardiovascular disease or heart failure (traditional indication based on classical Chinese medicine formulation).
Huangqi-Guizhi-Wuwu granules is a traditional Chinese medicine formulation that enhances immune function and improves microcirculation to support cardiovascular health.
Huangqi-Guizhi-Wuwu granules is a traditional Chinese medicine formulation that enhances immune function and improves microcirculation to support cardiovascular health. Used for Cardiovascular disease or heart failure (traditional indication based on classical Chinese medicine formulation).
At a glance
| Generic name | Huangqi-Guizhi-Wuwu granules |
|---|---|
| Sponsor | Nanjing NingQi Medicine Science and Technology Co., Ltd. |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
This herbal granule combines five classical Chinese medicinal ingredients (Astragalus/Huangqi, Cinnamon twig/Guizhi, and three other components) traditionally used to tonify qi, warm yang, and promote blood circulation. The formulation is designed to address underlying deficiencies in immune and cardiovascular function through multi-component herbal synergy rather than targeting a single molecular pathway.
Approved indications
- Cardiovascular disease or heart failure (traditional indication based on classical Chinese medicine formulation)
Common side effects
Key clinical trials
- Yiqi Wenjing Prescriptions Preventive Efficacy of Oxaliplatin-induced Peripheral Neuropathy Clinical Trial (PHASE3)
- Clinical Trial Scheme of Huangqi Guizhi Wuwu Decoction (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Huangqi-Guizhi-Wuwu granules CI brief — competitive landscape report
- Huangqi-Guizhi-Wuwu granules updates RSS · CI watch RSS
- Nanjing NingQi Medicine Science and Technology Co., Ltd. portfolio CI
Frequently asked questions about Huangqi-Guizhi-Wuwu granules
What is Huangqi-Guizhi-Wuwu granules?
How does Huangqi-Guizhi-Wuwu granules work?
What is Huangqi-Guizhi-Wuwu granules used for?
Who makes Huangqi-Guizhi-Wuwu granules?
What development phase is Huangqi-Guizhi-Wuwu granules in?
Related
- Manufacturer: Nanjing NingQi Medicine Science and Technology Co., Ltd. — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Cardiovascular disease or heart failure (traditional indication based on classical Chinese medicine formulation)
- Compare: Huangqi-Guizhi-Wuwu granules vs similar drugs
- Pricing: Huangqi-Guizhi-Wuwu granules cost, discount & access